Arylazole derivatives, their manufacture and use as pharmaceutical agents

US7259262B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Birgit Bossenmaier · Hanerau-Hademarschen, DE
• Walter-Gunar Friebe · Mannheim, DE
• Ulrike Reiff · Penzberg, DE
• Matthias Rueth · Penzberg, DE
• Edgar Voss · Bichl, DE

Key dates

• Filing date: Oct 15, 2004
• Grant date: Aug 21, 2007
• Expiry date: Nov 8, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

There are presented compounds of formula (I)their pharmaceutically acceptable salts, enantiomeric forms thereof, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.